Supplementary Figure S1 from A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma

Authors

Publication Details

Published
2025-10-01
DOI
https://doi.org/10.1158/1078-0432.30255122
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplementary Figure S1 from A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma

Jason R. Westin, Alexander Nesmelov, Noel English, Luis Fayad et al.
Lymphoma Diagnosis and Treatment
article

Supplementary Figure S1 from A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma

Jason R. Westin, Alexander Nesmelov, Noel English, Luis Fayad, Paolo Strati, Jared Henderson, Sairah Ahmed, Elizabeth McChesney, Dai Chihara, Sattva Swarup Neelapu, Tony Zhuang, Christopher R. Flowers, Lei Feng, Andrey Tyshevich, Julia Alesse, Nikita Syzrantsev, Elizabeth Sheehan, Karin M. Dent, Darya Shavronskaya
article en

Abstract

No abstract available for this paper.
Openalex Percentile: Top 62%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.